ArticleCancer cell international2023

An antisense amido-bridged nucleic acid gapmer oligonucleotide targeting SRRM4 alters REST splicing and exhibits anti-tumor effects in small cell lung cancer and prostate cancer cells.

Misa Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.